tirzepatide vs semaglutide vs retatrutide – What NO ONE Tells You what is the difference between

Tirzepatide (Mounjaro) is a prescription-only injectable medicine acting on GIP and GLP-1 pathways

The mechanism of action involves dual agonism at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors

Some people benefit from staying at each dose for 6 to 8 weeks before increasing, especially if they experience side effects that take time to resolve

When prescribed and monitored by a licensed healthcare professional and sourced from a reputable and legitimate compounding pharmacy, the use of tirzepatide with niacinamide is considered safe in common practice

When prescribed by a licensed provider and clinically appropriate, NexLife may facilitate access to compounded semaglutide or compounded tirzepatide prepared by U.S.-licensed compounding pharmacies operating under state board oversight and applicable sterile compounding standards, including USP

I changed pharmacies and the new vial looks different